All FDA articles – Page 6
-
Business
US focuses pharma supply chain scrutiny
Import pre-authorisation for trusted firms frees up resources to tackle purity problems
-
NewsPoliticians accuse US food agency of illegally monitoring employees
Republican staff report calls the Food and Drug Administration’s surveillance of whistleblowers unlawful
-
Business
US blocks imports from fourth Ranbaxy plant
FDA bans import of active ingredients from factory in Toansa, India
-
-
NewsFDA wants the dirt on antibacterial soaps
US manufacturers will have to prove their products are safe and more effective than ordinary soap, under a proposed rule
-
Opinion
Cut price pills cost more than pennies
We can’t afford to let the demand for cheaper medicines force compromises on quality, says Steven Ford
-
BusinessNew wave of hepatitis C drugs hits US shore
J&J’s once-daily drug approved by FDA, but rivals are hot on its heels
-
Business
US turnaround on Avandia restrictions
Researchers accuse regulator of face-saving U-turn over diabetes medication safety
-
Business
Regulator cracks down on 23andMe
Personal genetic profiler ordered to stop selling DNA test kits
-
BusinessPharma manufacturing woes dog industry
Regulators are stepping up inspections, and discovering ever more problems
-
Business
Roche backs biologics boom
Swiss firm to invest heavily in manufacturing for complex biological drugs
-
Business
First biosimilar antibody drugs approved in Europe
European commission gives final approval to generic infliximab copies
-
NewsExecution drug cannot be imported into US
Court rules that the Food and Drug Administration acted unlawfully allowing sodium thiopental into the country
-
Business
Big data to sniff out drug marketing fraud
US Food and Drug Administration wants to track promotional spending to spot off-label marketing
-
Business
Two new ‘personalised’ cancer drugs approved
Suitable patients for GSK’s melanoma treatments must be identified using an accompanying genetic test
-
Business
Portable detector shines light on fake drugs
Testing for counterfeit antimalarials in Africa will help validate a new tool for inspectors
-
Business
Morning sickness drug reintroduced to US
After being withdrawn due to litigation, the drug has been approved by the FDA
-
Business2012 pharma industry roundup
What were the bigger stories? And how did the industry fare overall?